Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism.

Schop D, van Dijkhuizen-Radersma R, Borgart E, Janssen FW, Rozemuller H, Prins HJ, de Bruijn JD.

J Tissue Eng Regen Med. 2010 Feb;4(2):131-40. doi: 10.1002/term.224.

PMID:
19842106
2.

Human tissue-engineered bone produced in clinically relevant amounts using a semi-automated perfusion bioreactor system: a preliminary study.

Janssen FW, van Dijkhuizen-Radersma R, Van Oorschot A, Oostra J, de Bruijn JD, Van Blitterswijk CA.

J Tissue Eng Regen Med. 2010 Jan;4(1):12-24. doi: 10.1002/term.197.

PMID:
19834955
3.

Growth, metabolism, and growth inhibitors of mesenchymal stem cells.

Schop D, Janssen FW, van Rijn LD, Fernandes H, Bloem RM, de Bruijn JD, van Dijkhuizen-Radersma R.

Tissue Eng Part A. 2009 Aug;15(8):1877-86. doi: 10.1089/ten.tea.2008.0345.

PMID:
19196147
4.

Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism.

Schop D, Janssen FW, Borgart E, de Bruijn JD, van Dijkhuizen-Radersma R.

J Tissue Eng Regen Med. 2008 Mar-Apr;2(2-3):126-35. doi: 10.1002/term.73.

PMID:
18348332
5.

Online measurement of oxygen consumption by goat bone marrow stromal cells in a combined cell-seeding and proliferation perfusion bioreactor.

Janssen FW, Hofland I, van Oorschot A, Oostra J, Peters H, van Blitterswijk CA.

J Biomed Mater Res A. 2006 Nov;79(2):338-48.

PMID:
16878315
6.

Report of a collaborative trial to investigate the performance of the R5 enzyme linked immunoassay to determine gliadin in gluten-free food.

Méndez E, Vela C, Immer U, Janssen FW.

Eur J Gastroenterol Hepatol. 2005 Oct;17(10):1053-63.

PMID:
16148550
7.

A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept.

Janssen FW, Oostra J, Oorschot Av, van Blitterswijk CA.

Biomaterials. 2006 Jan;27(3):315-23. Epub 2005 Aug 25.

PMID:
16125223
8.

Analysis and clinical effects of gluten in coeliac disease.

Stern M, Ciclitira PJ, van Eckert R, Feighery C, Janssen FW, Méndez E, Mothes T, Troncone R, Wieser H.

Eur J Gastroenterol Hepatol. 2001 Jun;13(6):741-7. Review.

PMID:
11434606
9.

[MRI study of left ventricular function in patients with coronary disease and myocardial dysfunction before and after coronary revascularization].

Juergens KU, Wichter T, Renger B, Bruns HJ, Reimer P, Tombach B, Vahlhaus C, Janssen FW, Breithardt G, Heindel W.

Rofo. 2001 Mar;173(3):211-7. German.

PMID:
11293862
10.

Signal characteristics of multichannel epicardial electrograms in chronic ischaemic and scarred myocardium: electromechanical mismatch indicates viability in regions of myocardial dysfunction.

Bruns HJ, Janssen FW, Schäfers M, Hammel D, Fetsch T, Arslan O, Krenz M, Vahlhaus C, Borggrefe M, Scheld HH, Schober O, Breithardt G, Wichter T.

Basic Res Cardiol. 2001 Feb;96(1):98-105.

PMID:
11215538
11.

[Is 'gluten-free' outlawed?].

Köhler-Brands L, Tan AC, Mulder CJ, Janssen FW.

Ned Tijdschr Geneeskd. 1994 Dec 17;138(51):2541-4. Dutch. No abstract available.

PMID:
7830802
12.

Interactions between oxaprozin glucuronide and human serum albumin.

Wells DS, Janssen FW, Ruelius HW.

Xenobiotica. 1987 Dec;17(12):1437-49.

PMID:
3439193
13.

Detection of soya proteins in heated meat products by "blotting" and "dot blot".

Janssen FW, Voortman G, de Baaij JA.

Z Lebensm Unters Forsch. 1986 Jun;182(6):479-83.

PMID:
3529711
14.

Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin.

Ruelius HW, Kirkman SK, Young EM, Janssen FW.

Adv Exp Med Biol. 1986;197:431-41.

PMID:
3766273
15.

Oxaprozin dose proportionality.

Chiang ST, Lasseter KC, Fluck ER, Janssen FW, Leelavathi D, Hubsher JA.

J Clin Pharmacol. 1984 Nov-Dec;24(11-12):515-22.

PMID:
6511991
16.

Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronide.

Janssen FW, Kirkman SK, Fenselau C, Stogniew M, Hofmann BR, Young EM, Ruelius HW.

Drug Metab Dispos. 1982 Nov-Dec;10(6):599-604.

PMID:
6130907
17.

Protein binding and clearance of oxaprozin, a highly bound anti-inflammatory agent.

Homon CA, Fluck ER, Janssen FW, Ruelius HW.

Agents Actions. 1982 Apr;12(1-2):211-5.

PMID:
7080958
18.

Biotransformation of the immunomodulator, 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazolo[3,2a]benzimidazole-2-acetic acid, and its relationship to thyroid toxicity.

Janssen FW, Young EM, Kirkman SK, Sharma RN, Ruelius HW.

Toxicol Appl Pharmacol. 1981 Jun 30;59(2):355-63. No abstract available.

PMID:
7256773
19.

Metabolism and kinetics of oxaprozin in normal subjects.

Janssen FW, Jusko WJ, Chiang ST, Kirkman SK, Southgate PJ, Coleman AJ, Ruelius HW.

Clin Pharmacol Ther. 1980 Mar;27(3):352-62.

PMID:
7357792
20.

Disposition of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) in beagle dogs and rhesus monkeys.

Janssen FW, Kirkman SK, Knowles JA, Ruelius HW.

Drug Metab Dispos. 1978 Jul-Aug;6(4):465-75.

PMID:
28928
21.
22.

Alcohol oxidase from Basidiomycetes.

Janssen FW, Kerwin RM, Ruelius HW.

Methods Enzymol. 1975;41:364-9. No abstract available.

PMID:
236460
23.

Pyranose oxidase from Polyporus obtusus.

Janssen FW, Ruelius HW.

Methods Enzymol. 1975;41:170-3. No abstract available.

PMID:
236434
24.

Metabolic and pathologic investigation of 1-aminocyclohexanecarboxylic acid (ACHC), a metabolite of 6-(1-aminocyclohexanecarboxamido)-penicillanic acid (cyclacillin).

Janssen FW, Young EM, Kirkman SK, Agersborg HP Jr, Tucker WE Jr, Ruelius HW.

Toxicol Appl Pharmacol. 1974 Jul;29(1):19-34. No abstract available.

PMID:
4378191
25.

Sex- and species-related nephropathy of 6-(1-aminocyclohexanecarboxamido)penicillanic acid (cyclacillin) and its relationship to the metabolic disposition of the drug.

Tucker WE Jr, Janssen FW, Agersborg HP Jr, Young EM, Ruelius HW.

Toxicol Appl Pharmacol. 1974 Jul;29(1):1-18. No abstract available.

PMID:
4283678
26.

Effect of L-valine on renal excretion, blood concentrations and toxicity of cycloleucine in mice.

Ruelius HW, Gregory FJ, Kirkman SK, Warren GH, Janssen FW.

Biochem Pharmacol. 1973 Jun 1;22(11):1379-83. No abstract available.

PMID:
4727787
27.

Determination of cycloleucine in biological fluids.

Janssen FW, Knowles JA, Kirkman SK, Ruelius HW.

Anal Biochem. 1969 Aug;30(2):217-21. No abstract available.

PMID:
5809664
28.

Carbohydrate oxidase, a novel enzyme from Polyporus obtusus. I. Isolation and purification.

Ruelius HW, Kerwin RM, Janssen FW.

Biochim Biophys Acta. 1968 Nov 19;167(3):493-500. No abstract available.

PMID:
5725162
29.

Carbohydrate oxidase, a novel enzyme from Polyporus obtusus. II. Specificity and characterization of reaction products.

Janssen FW, Ruelius HW.

Biochim Biophys Acta. 1968 Nov 19;167(3):501-10. No abstract available.

PMID:
5722278
30.

Poricin, an acidic protein with antitumor activity from a basidiomycete. I. Production, isolation, and purification.

Ruelius HW, Janssen FW, Kerwin RM, Goodwin CW, Schillings RT.

Arch Biochem Biophys. 1968 Apr;125(1):126-35. No abstract available.

PMID:
5689771
31.

Alcohol oxidase, a flavoprotein from several Basidiomycetes species. Crystallization by fractional precipitation with polyethylene glycol.

Janssen FW, Ruelius HW.

Biochim Biophys Acta. 1968 Feb 5;151(2):330-42. No abstract available.

PMID:
5636370
32.

Alcohol oxidase, a novel enzyme from a basidiomycete.

Janssen FW, Kerwin RM, Ruelius HW.

Biochem Biophys Res Commun. 1965 Sep 8;20(5):630-4. No abstract available.

PMID:
5864845
33.

Colorimetric assay for dipicolinic acid in bacterial spores.

JANSSEN FW, LUND AJ, ANDERSON LE.

Science. 1958 Jan 3;127(3288):26-7. No abstract available.

PMID:
13495474
34.

Effect of culture filtrates on sporogenesis in a species of Clostridium.

LUND AJ, JANSSEN FW, ANDERSON LE.

J Bacteriol. 1957 Nov;74(5):577-83. No abstract available.

Supplemental Content

Loading ...
Support Center